TY - JOUR
T1 - Genetic Variation in the alpha 7 Nicotinic Acetylcholine Receptor is Associated with Delusional Symptoms in Alzheimer's Disease
AU - Carson, R.
AU - Craig, David
AU - Hart, D.
AU - Todd, Stephen
AU - McCuinness, B.
AU - Johnston, James
AU - O'Neill, Francis
AU - Ritchie, C.W.
AU - Passmore, Peter
PY - 2008/12
Y1 - 2008/12
N2 - Psychotic symptoms are common in Alzheimer's disease (AD) and have a negative impact oil quality of life. It is suggested that psychotic symptoms may be attributed to genetic risk factors which are revealed during neurodegeneration. CHRNA7, the gene for the alpha 7 nicotinic acetylcholine receptor, has been associated with schizophrenia in linkage and association Studies. Hence we investigated single SNPs and haplotypes in CHRNA7 in relation to AD with psychosis in a large, well-characterised and previously described cohort within the Northern Ireland population. A significant association between delusions and the T allele of rs6494223 (P = 0.014, OR = 1.63, Cl 1.22-2.17) was found. This suggests that the alpha 7 receptor may be a suitable target for the treatment of AD with psychosis.
AB - Psychotic symptoms are common in Alzheimer's disease (AD) and have a negative impact oil quality of life. It is suggested that psychotic symptoms may be attributed to genetic risk factors which are revealed during neurodegeneration. CHRNA7, the gene for the alpha 7 nicotinic acetylcholine receptor, has been associated with schizophrenia in linkage and association Studies. Hence we investigated single SNPs and haplotypes in CHRNA7 in relation to AD with psychosis in a large, well-characterised and previously described cohort within the Northern Ireland population. A significant association between delusions and the T allele of rs6494223 (P = 0.014, OR = 1.63, Cl 1.22-2.17) was found. This suggests that the alpha 7 receptor may be a suitable target for the treatment of AD with psychosis.
UR - http://www.scopus.com/inward/record.url?scp=65249151342&partnerID=8YFLogxK
U2 - 10.1007/s12017-008-8048-8
DO - 10.1007/s12017-008-8048-8
M3 - Article
C2 - 18696274
SN - 1559-1174
VL - 10
SP - 377
EP - 384
JO - NeuroMolecular Medicine
JF - NeuroMolecular Medicine
IS - 4
ER -